Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new publication citation by Leighl NB et al. was added to the Publications section. The citation describes a plain-language summary of subcutaneous versus intravenous amivantamab plus lazertinib in EGFR-mutated NSCLC and notes that it is online ahead of print.
    Difference
    0.0%
    Check dated 2026-08-25T19:47:04.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page's version metadata rather than any changes to study content.
    Difference
    0.0%
    Check dated 2026-08-11T22:13:04.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    Two new update dates (2026-07-31 and 2026-07-30) were added and two earlier dates (2026-07-06 and 2026-07-02) were removed from the study's record history, reflecting maintenance of the listing's update chronology.
    Difference
    0.1%
    Check dated 2026-08-04T23:26:32.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision number was updated from v3.6.3 to v3.6.4, signaling a small platform or content update rather than a change to study data.
    Difference
    0.0%
    Check dated 2026-07-21T13:47:02.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    New update timestamps (2026-07-06, 2026-07-02, 2026-07) were added and older ones (2026-06-08, 2026-06-04, 2026-06) removed in the study's record dates, reflecting the current update chronology.
    Difference
    0.1%
    Check dated 2026-07-07T09:51:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.0 to v3.6.3, indicating a newer version of the page. This appears to be a revision history update rather than a substantive change to the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-30T05:40:48.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.